Skip to main content
Erschienen in: Environmental Health and Preventive Medicine 2/2009

01.03.2009 | Review

Molecular epidemiology of major depressive disorder

verfasst von: Chikako Kiyohara, Kouichi Yoshimasu

Erschienen in: Environmental Health and Preventive Medicine | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Major depressive disorder causes significant morbidity, affecting people’s ability to work, function in relationships, and engage in social activities. Moreover, major depressive disorder increases the risk of suicidal ideation, attempted suicide and death by completed suicide. There is evidence that chronic stress can cause major depressive disorder. As for genetic factors, only minor susceptibility genes have been reliably identified. The serotonin system provides a logical source of susceptibility genes for depression, because this system is the target of selective serotonin reuptake-inhibitor drugs that are effective in treating depression. The 5-hydroxytryptamine (serotonin) transporter (5-HTT) has received particular attention because it is involved in the reuptake of serotonin at brain synapses. One common polymorphic variant of the 5-HTT-linked polymorphic region (5-HTTLPR), which affects the promoter of the 5-HTT gene, causes reduced uptake of the neurotransmitter serotonin into the presynaptic cells in the brain. The authors discussed the relationship between genetic polymorphisms and major depressive disorder, with special emphasis on the 5-HTTTLPR polymorphism. As the 5-HTTLPR polymorphism was significantly associated with an increased risk of major depressive disorder, the 5-HTT gene may be a candidate for a major depressive disorder susceptibility gene. As major depressive disorder is a multifactorial disease, an improved understanding of the interplay of environmental and genetic polymorphisms at multiple loci may help identify individuals who are at increased risk for major depressive disorder. Hopefully, in the future we will be able to screen for major depressive disorder susceptibility by using specific biomarkers.
Literatur
2.
Zurück zum Zitat American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 1994. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 1994.
3.
Zurück zum Zitat Guze SB, Robins E. Suicide and primary affective disorders. Br J Psychiatry. 1970;117:437–8.PubMedCrossRef Guze SB, Robins E. Suicide and primary affective disorders. Br J Psychiatry. 1970;117:437–8.PubMedCrossRef
4.
Zurück zum Zitat Kapur S, Mieczkowski T, Mann JJ. Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA. 1992;268:3441–5.PubMedCrossRef Kapur S, Mieczkowski T, Mann JJ. Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA. 1992;268:3441–5.PubMedCrossRef
5.
Zurück zum Zitat Nierenberg AA, Gray SM, Grandin LD. Mood disorders and suicide. J Clin Psychiatry. 2001;62(Suppl 25):27–30.PubMed Nierenberg AA, Gray SM, Grandin LD. Mood disorders and suicide. J Clin Psychiatry. 2001;62(Suppl 25):27–30.PubMed
6.
Zurück zum Zitat American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV-TR). 4th ed. Washington: American Psychiatric Publishing Inc; 2000. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV-TR). 4th ed. Washington: American Psychiatric Publishing Inc; 2000.
7.
Zurück zum Zitat Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An international study of the relation between somatic symptoms and depression. N Engl J Med. 1999;341:1329–35.PubMedCrossRef Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An international study of the relation between somatic symptoms and depression. N Engl J Med. 1999;341:1329–35.PubMedCrossRef
10.
Zurück zum Zitat Japanese Ministry of Health, Labor and Welfare. Vital statistics of Japan 2005. Tokyo: Health and Welfare Statistics Association; 2006. Japanese Ministry of Health, Labor and Welfare. Vital statistics of Japan 2005. Tokyo: Health and Welfare Statistics Association; 2006.
11.
Zurück zum Zitat Kendler KS. Overview: a current perspective on twin studies of schizophrenia. Am J Psychiatry. 1983;140:1413–25.PubMed Kendler KS. Overview: a current perspective on twin studies of schizophrenia. Am J Psychiatry. 1983;140:1413–25.PubMed
12.
Zurück zum Zitat Kessler RC. The effects of stressful life events on depression. Annu Rev Psychol. 1997;48:191–214.PubMedCrossRef Kessler RC. The effects of stressful life events on depression. Annu Rev Psychol. 1997;48:191–214.PubMedCrossRef
13.
Zurück zum Zitat Mazure CM. Life stressors as risk factors in depression. Clin Psychol Sci Pract. 1998;5:291–313.CrossRef Mazure CM. Life stressors as risk factors in depression. Clin Psychol Sci Pract. 1998;5:291–313.CrossRef
14.
Zurück zum Zitat Monroe SM, Hadjiyannakis K. The social environment and depression: focusing on severe life stress. In: Gotlib IH, Hammen CL, editors. Handbook of Depression. New York: Guilford Press; 2002. p. 314–40. Monroe SM, Hadjiyannakis K. The social environment and depression: focusing on severe life stress. In: Gotlib IH, Hammen CL, editors. Handbook of Depression. New York: Guilford Press; 2002. p. 314–40.
15.
Zurück zum Zitat Tennant C. Life events, stress and depression: a review of the findings. Aust NZ J Psychiatry. 2002;36:173–82.CrossRef Tennant C. Life events, stress and depression: a review of the findings. Aust NZ J Psychiatry. 2002;36:173–82.CrossRef
16.
Zurück zum Zitat Paykel ES. Life events and affective disorders. Acta Psychiatr Scand. 2003;108:61–6.CrossRef Paykel ES. Life events and affective disorders. Acta Psychiatr Scand. 2003;108:61–6.CrossRef
19.
Zurück zum Zitat Wong ML, Licinio J. Research and treatment approaches to depression. Nat Rev Neurosci. 2001;2:343–51.PubMedCrossRef Wong ML, Licinio J. Research and treatment approaches to depression. Nat Rev Neurosci. 2001;2:343–51.PubMedCrossRef
20.
Zurück zum Zitat Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527–31.PubMedCrossRef Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527–31.PubMedCrossRef
21.
Zurück zum Zitat Edgerton JE, Campbell RE, editors. American psychiatric glossary. 7th ed. Washington: American Psychiatric Press Inc; 1994. Edgerton JE, Campbell RE, editors. American psychiatric glossary. 7th ed. Washington: American Psychiatric Press Inc; 1994.
22.
Zurück zum Zitat Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61:807–16.PubMedCrossRef Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61:807–16.PubMedCrossRef
23.
Zurück zum Zitat Goetzel RZ, Hawkins K, Ozminski RJ. The health and productivity cost burden of the “top 10” physical and mental conditions affecting six large US employers in 1999. J Occup Environ Med. 2003;45:5–14.PubMedCrossRef Goetzel RZ, Hawkins K, Ozminski RJ. The health and productivity cost burden of the “top 10” physical and mental conditions affecting six large US employers in 1999. J Occup Environ Med. 2003;45:5–14.PubMedCrossRef
24.
Zurück zum Zitat Murray CJ, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge: Harvard University Press; 1996. Murray CJ, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge: Harvard University Press; 1996.
25.
Zurück zum Zitat Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry. 2004;184:386–92.PubMedCrossRef Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry. 2004;184:386–92.PubMedCrossRef
26.
Zurück zum Zitat WHO International Consortium in Psychiatric Epidemiology. Cross-national comparisons of the prevalences and correlates of mental disorders Bulletin of the World Health Organization v.78 n.4. 2000. WHO International Consortium in Psychiatric Epidemiology. Cross-national comparisons of the prevalences and correlates of mental disorders Bulletin of the World Health Organization v.78 n.4. 2000.
29.
Zurück zum Zitat Andrews G, Henderson S, Hall W. Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey. Br J Psychiatry. 2001;178:145–53.PubMedCrossRef Andrews G, Henderson S, Hall W. Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey. Br J Psychiatry. 2001;178:145–53.PubMedCrossRef
30.
Zurück zum Zitat Bijl RV, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol. 1998;33:587–95.PubMedCrossRef Bijl RV, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol. 1998;33:587–95.PubMedCrossRef
31.
Zurück zum Zitat Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19.PubMed Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19.PubMed
32.
Zurück zum Zitat Offord DR, Boyle MH, Campbell D, Goering P, Lin E, Wong M, et al. One-year prevalence of psychiatric disorder in Ontarians 15–64 years of age. Can J Psychiatry. 1996;41:559–63.PubMed Offord DR, Boyle MH, Campbell D, Goering P, Lin E, Wong M, et al. One-year prevalence of psychiatric disorder in Ontarians 15–64 years of age. Can J Psychiatry. 1996;41:559–63.PubMed
33.
Zurück zum Zitat Regier DA, Boyd JH, Burke JD Jr, Rae DS, Myers JK, Kramer M, et al. One-month prevalence of mental disorders in the United States. Based on five epidemiologic catchment area sites. Arch Gen Psychiatry. 1988;45:977–86.PubMed Regier DA, Boyd JH, Burke JD Jr, Rae DS, Myers JK, Kramer M, et al. One-month prevalence of mental disorders in the United States. Based on five epidemiologic catchment area sites. Arch Gen Psychiatry. 1988;45:977–86.PubMed
34.
Zurück zum Zitat Evans K, McGrath J, Milns R. Searching for schizophrenia in ancient Greek and Roman literature: a systematic review. Acta Psychiatr Scand. 2003;107:323–30.PubMedCrossRef Evans K, McGrath J, Milns R. Searching for schizophrenia in ancient Greek and Roman literature: a systematic review. Acta Psychiatr Scand. 2003;107:323–30.PubMedCrossRef
35.
Zurück zum Zitat Weissman MM, Bland R, Joyce PR, Newman S, Wells JE, Wittchen H-U. Sex differences in rates of depression: cross-national perspectives. J Affect Disord. 1993;29:77–84.PubMedCrossRef Weissman MM, Bland R, Joyce PR, Newman S, Wells JE, Wittchen H-U. Sex differences in rates of depression: cross-national perspectives. J Affect Disord. 1993;29:77–84.PubMedCrossRef
36.
Zurück zum Zitat Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey. I: lifetime prevalence, chronicity and recurrence. J Affect Disord. 1993;29:85–96.PubMedCrossRef Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey. I: lifetime prevalence, chronicity and recurrence. J Affect Disord. 1993;29:85–96.PubMedCrossRef
37.
Zurück zum Zitat Gater R, Tansella M, Korten A, Tiemens BG, Mavreas VG, Olatawura MO. Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings. Arch Gen Psychiatry. 1998;55:405–13.PubMedCrossRef Gater R, Tansella M, Korten A, Tiemens BG, Mavreas VG, Olatawura MO. Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings. Arch Gen Psychiatry. 1998;55:405–13.PubMedCrossRef
38.
Zurück zum Zitat Bennett DS, Ambrosini PJ, Kudes D, Metz C, Rabinovich H. Gender differences in adolescent depression: do symptoms differ for boys and girls? J Affect Disord. 2005;89:35–44.PubMedCrossRef Bennett DS, Ambrosini PJ, Kudes D, Metz C, Rabinovich H. Gender differences in adolescent depression: do symptoms differ for boys and girls? J Affect Disord. 2005;89:35–44.PubMedCrossRef
39.
Zurück zum Zitat Bernal M, Haro JM, Bernert S, Brugha T, de Graaf R, Bruffaerts R, et al. Risk factors for suicidality in Europe: results from the ESEMED study. J Affect Disord. 2007;101:27–34.PubMedCrossRef Bernal M, Haro JM, Bernert S, Brugha T, de Graaf R, Bruffaerts R, et al. Risk factors for suicidality in Europe: results from the ESEMED study. J Affect Disord. 2007;101:27–34.PubMedCrossRef
40.
Zurück zum Zitat Hawton K. Sex and suicide. Gender differences in suicidal behaviour. Br J Psychiatry. 2000;177:484–5.PubMedCrossRef Hawton K. Sex and suicide. Gender differences in suicidal behaviour. Br J Psychiatry. 2000;177:484–5.PubMedCrossRef
41.
Zurück zum Zitat Biddle L, Gunnell D, Sharp D, Donovan JL. Factors influencing help seeking in mentally distressed young adults: a cross-sectional survey. Br J Gen Pract. 2004;54:248–53.PubMed Biddle L, Gunnell D, Sharp D, Donovan JL. Factors influencing help seeking in mentally distressed young adults: a cross-sectional survey. Br J Gen Pract. 2004;54:248–53.PubMed
42.
Zurück zum Zitat Bogner HR, Gallo JJ. Are higher rates of depression in women accounted for by differential symptom reporting? Soc Psychiatry Psychiatr Epidemiol. 2004;39:126–32.PubMedCrossRef Bogner HR, Gallo JJ. Are higher rates of depression in women accounted for by differential symptom reporting? Soc Psychiatry Psychiatr Epidemiol. 2004;39:126–32.PubMedCrossRef
43.
Zurück zum Zitat Gunnell D, Rasul F, Stansfeld SA, Hart CL, Davey SG. Gender differences in self-reported minor mental disorder and its association with suicide. A 20-year follow-up of the Renfrew and Paisley cohort. Soc Psychiatry Psychiatr Epidemiol. 2002;37:457–9.PubMedCrossRef Gunnell D, Rasul F, Stansfeld SA, Hart CL, Davey SG. Gender differences in self-reported minor mental disorder and its association with suicide. A 20-year follow-up of the Renfrew and Paisley cohort. Soc Psychiatry Psychiatr Epidemiol. 2002;37:457–9.PubMedCrossRef
44.
Zurück zum Zitat Haynie DA, Berg S, Johansson B, Gatz M, Zarit SH. Symptoms of depression in the oldest old: a longitudinal study. J Gerontol B Psychol Sci Soc Sci. 2001;56:P111–8.PubMed Haynie DA, Berg S, Johansson B, Gatz M, Zarit SH. Symptoms of depression in the oldest old: a longitudinal study. J Gerontol B Psychol Sci Soc Sci. 2001;56:P111–8.PubMed
45.
Zurück zum Zitat Kasen S, Cohen P, Chen H, Castille D. Depression in adult women: age changes and cohort effects. Am J Public Health. 2003;93:2061–6.PubMedCrossRef Kasen S, Cohen P, Chen H, Castille D. Depression in adult women: age changes and cohort effects. Am J Public Health. 2003;93:2061–6.PubMedCrossRef
46.
Zurück zum Zitat Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276:293–9.PubMedCrossRef Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276:293–9.PubMedCrossRef
47.
Zurück zum Zitat Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry. 1994;151:979–86.PubMed Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry. 1994;151:979–86.PubMed
48.
Zurück zum Zitat Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder. JAMA. 2003;289:3095–105.PubMedCrossRef Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder. JAMA. 2003;289:3095–105.PubMedCrossRef
49.
Zurück zum Zitat US Department of Health and Human Services. Mental health: culture, race, and ethnicity: a supplement to mental health: a report of the surgeon general—executive summary. Rockville: US Dept of Health and Human Services, Public Health Service, Office of the Surgeon General; 2001. US Department of Health and Human Services. Mental health: culture, race, and ethnicity: a supplement to mental health: a report of the surgeon general—executive summary. Rockville: US Dept of Health and Human Services, Public Health Service, Office of the Surgeon General; 2001.
50.
Zurück zum Zitat Breslau J, Kendler KS, Su M, Gaxiola-Aguilar S, Kessler RC. Lifetime risk and persistence of psychiatric disorders across ethnic groups in the United States. Psychol Med. 2005;35:317–27.PubMedCrossRef Breslau J, Kendler KS, Su M, Gaxiola-Aguilar S, Kessler RC. Lifetime risk and persistence of psychiatric disorders across ethnic groups in the United States. Psychol Med. 2005;35:317–27.PubMedCrossRef
51.
Zurück zum Zitat Waraich P, Goldner EM, Somers JM, Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 2004;49:124–38.PubMed Waraich P, Goldner EM, Somers JM, Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 2004;49:124–38.PubMed
52.
Zurück zum Zitat Dunlop DD, Song J, Lyons JS, Manheim LM, Chang RW. Racial/ethnic differences in rates of depression among preretirement adults. Am J Public Health. 2003;93:1945–52.PubMedCrossRef Dunlop DD, Song J, Lyons JS, Manheim LM, Chang RW. Racial/ethnic differences in rates of depression among preretirement adults. Am J Public Health. 2003;93:1945–52.PubMedCrossRef
53.
Zurück zum Zitat Kawakami N, Takeshima T, Ono Y, Uda H, Hata Y, Nakane Y, et al. Twelve-month prevalence, severity, and treatment of common mental disorders in communities in Japan: preliminary finding from the World Mental Health Japan Survey 2002–2003. Psychiatry Clin Neurosci 2005; 59:441–52. Kawakami N, Takeshima T, Ono Y, Uda H, Hata Y, Nakane Y, et al. Twelve-month prevalence, severity, and treatment of common mental disorders in communities in Japan: preliminary finding from the World Mental Health Japan Survey 2002–2003. Psychiatry Clin Neurosci 2005; 59:441–52.
55.
Zurück zum Zitat Riolo SA, Nguyen TA, Greden JF, King CA. Prevalence of depression by race/ethnicity: findings from the National Health and Nutrition Examination Survey III. Am J Public Health. 2005;95:998–1000.PubMedCrossRef Riolo SA, Nguyen TA, Greden JF, King CA. Prevalence of depression by race/ethnicity: findings from the National Health and Nutrition Examination Survey III. Am J Public Health. 2005;95:998–1000.PubMedCrossRef
56.
Zurück zum Zitat Straub RH, Dhabhar FS, Bijlsma JW, Cutolo M. How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis. Arthr Rheum. 2005;52:16–26.CrossRef Straub RH, Dhabhar FS, Bijlsma JW, Cutolo M. How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis. Arthr Rheum. 2005;52:16–26.CrossRef
57.
Zurück zum Zitat Dhabhar FS, McEwen BS. Acute stress enhances while chronic stress suppresses immune function in vivo: a potential role for leukocyte trafficking. Brain Behav Immun. 1997;11:286–306.PubMedCrossRef Dhabhar FS, McEwen BS. Acute stress enhances while chronic stress suppresses immune function in vivo: a potential role for leukocyte trafficking. Brain Behav Immun. 1997;11:286–306.PubMedCrossRef
58.
Zurück zum Zitat Dhabhar FS, McEwen BS. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci USA. 1999;96:1059–64.PubMedCrossRef Dhabhar FS, McEwen BS. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci USA. 1999;96:1059–64.PubMedCrossRef
59.
Zurück zum Zitat Dhabhar FS, McEwen BS. Stress-induced enhancement of antigen-specific cell-mediated immunity. J. Immunol. 1996;156:2608–15.PubMed Dhabhar FS, McEwen BS. Stress-induced enhancement of antigen-specific cell-mediated immunity. J. Immunol. 1996;156:2608–15.PubMed
60.
Zurück zum Zitat McEwen BS. Protective and damaging effects of stress mediators: allostasis and allostatic load. N Engl J Med. 1998;338:171–9.PubMedCrossRef McEwen BS. Protective and damaging effects of stress mediators: allostasis and allostatic load. N Engl J Med. 1998;338:171–9.PubMedCrossRef
61.
Zurück zum Zitat Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000;92:994–1000.PubMedCrossRef Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000;92:994–1000.PubMedCrossRef
62.
Zurück zum Zitat Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 1984;5:25–44.PubMedCrossRef Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 1984;5:25–44.PubMedCrossRef
63.
Zurück zum Zitat Schleimer RP, Claman HN, Oronsky A, editors. Anti-inflammatory steroid action: basic and clinical aspect. San Diego: Academic Press, Inc.; 1989. Schleimer RP, Claman HN, Oronsky A, editors. Anti-inflammatory steroid action: basic and clinical aspect. San Diego: Academic Press, Inc.; 1989.
64.
Zurück zum Zitat Dohrenwend BP, Levav I, Shrout PE, Schwartz S, Naveh G, Link BG, et al. Socioeconomic status and psychiatric disorders: the causation-selection issue. Science. 1992;255:946–52.PubMedCrossRef Dohrenwend BP, Levav I, Shrout PE, Schwartz S, Naveh G, Link BG, et al. Socioeconomic status and psychiatric disorders: the causation-selection issue. Science. 1992;255:946–52.PubMedCrossRef
65.
Zurück zum Zitat Bruce ML, Hoff RA. Social and physical health risk factors for first-onset major depressive disorder in a community sample. Soc Psychiatry Psychiatr Epidemiol. 1994;29:165–71.PubMed Bruce ML, Hoff RA. Social and physical health risk factors for first-onset major depressive disorder in a community sample. Soc Psychiatry Psychiatr Epidemiol. 1994;29:165–71.PubMed
66.
Zurück zum Zitat Swindle RW, Cronkite RC, Moos RH. Life stressors, social resources, coping, and the 4-year course of unipolar depression. J Abnorm Psychol. 1989;98:468–77.PubMedCrossRef Swindle RW, Cronkite RC, Moos RH. Life stressors, social resources, coping, and the 4-year course of unipolar depression. J Abnorm Psychol. 1989;98:468–77.PubMedCrossRef
67.
68.
Zurück zum Zitat Breslau N, Davis GC. Chronic stress and major depression. Arch Gen Psychiatry. 1986;43:309–14.PubMed Breslau N, Davis GC. Chronic stress and major depression. Arch Gen Psychiatry. 1986;43:309–14.PubMed
69.
Zurück zum Zitat Paykel ES, Cooper Z. Life events and social stress. In: Paykel ES, editor. Handbook of affective disorder. New York: Guilford Press; 1992. p. 149–70. Paykel ES, Cooper Z. Life events and social stress. In: Paykel ES, editor. Handbook of affective disorder. New York: Guilford Press; 1992. p. 149–70.
70.
Zurück zum Zitat Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry. 2000;157:1552–62.PubMedCrossRef Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry. 2000;157:1552–62.PubMedCrossRef
71.
Zurück zum Zitat Bierut LJ, Heath AC, Bucholz KK, Dinwiddie SH, Madden PA, Statham DJ, et al. Major depressive disorder in a community-based twin sample: are there different genetic and environmental contributions for men and women? Arch Gen Psychiatry. 1999;56:557–63.PubMedCrossRef Bierut LJ, Heath AC, Bucholz KK, Dinwiddie SH, Madden PA, Statham DJ, et al. Major depressive disorder in a community-based twin sample: are there different genetic and environmental contributions for men and women? Arch Gen Psychiatry. 1999;56:557–63.PubMedCrossRef
72.
Zurück zum Zitat Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. The lifetime history of major depression in women. Reliability of diagnosis and heritability. Arch Gen Psychiatry. 1993;50:863–70.PubMed Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. The lifetime history of major depression in women. Reliability of diagnosis and heritability. Arch Gen Psychiatry. 1993;50:863–70.PubMed
73.
Zurück zum Zitat Kendler KS, Gardner CO, Neale MC, Prescott CA. Genetic risk factors for major depression in men and women: similar or different heritabilities and same or partly distinct genes? Psychol Med. 2001;31:605–16.PubMed Kendler KS, Gardner CO, Neale MC, Prescott CA. Genetic risk factors for major depression in men and women: similar or different heritabilities and same or partly distinct genes? Psychol Med. 2001;31:605–16.PubMed
74.
Zurück zum Zitat McGuffin P, Katz R, Rutherford J. Nature, nurture and depression: a twin study. Psychol Med. 1991;21:329–55.PubMedCrossRef McGuffin P, Katz R, Rutherford J. Nature, nurture and depression: a twin study. Psychol Med. 1991;21:329–55.PubMedCrossRef
75.
Zurück zum Zitat McGuffin P, Katz R, Watkins S, Rutherford J. A hospital-based twin register of the heritability of DSM-IV unipolar depression. Arch Gen Psychiatry. 1996;53:129–36.PubMed McGuffin P, Katz R, Watkins S, Rutherford J. A hospital-based twin register of the heritability of DSM-IV unipolar depression. Arch Gen Psychiatry. 1996;53:129–36.PubMed
76.
Zurück zum Zitat Torgersen S. Genetic factors in moderately severe and mild affective disorders. Arch Gen Psychiatry. 1986;43:222–6.PubMed Torgersen S. Genetic factors in moderately severe and mild affective disorders. Arch Gen Psychiatry. 1986;43:222–6.PubMed
77.
Zurück zum Zitat Mendlewicz J, Rainer JD. Adoption study supporting genetic transmission in manic-depressive illness. Nature. 1977;268:326–9.CrossRef Mendlewicz J, Rainer JD. Adoption study supporting genetic transmission in manic-depressive illness. Nature. 1977;268:326–9.CrossRef
78.
Zurück zum Zitat Cadoret R. Evidence for genetic inheritance of primary affective disorder in adoptees. Am J Psychiatry. 1978;133:463–6. Cadoret R. Evidence for genetic inheritance of primary affective disorder in adoptees. Am J Psychiatry. 1978;133:463–6.
79.
Zurück zum Zitat Wender PH, Kety SS, Rosenthal D, Schulsinger F, Ortmann J, Lunde I. Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch Gen Psychiatry. 1986;43:923–9.PubMed Wender PH, Kety SS, Rosenthal D, Schulsinger F, Ortmann J, Lunde I. Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch Gen Psychiatry. 1986;43:923–9.PubMed
80.
Zurück zum Zitat Gershon ES, Weissman MM, Guroff JJ, Prusoff BA, Leckman JF. Validation of criteria for major depression through controlled family study. J Affect Disord. 1986;11:125–31.PubMedCrossRef Gershon ES, Weissman MM, Guroff JJ, Prusoff BA, Leckman JF. Validation of criteria for major depression through controlled family study. J Affect Disord. 1986;11:125–31.PubMedCrossRef
81.
Zurück zum Zitat Weissman MM, Gershon ES, Kidd KK, Prusoff BA, Leckman JF, Dibble E, et al. Psychiatric disorders in the relatives of probands with affective disorders The Yale University, National Institute of Mental Health Collaborative Study. Arch Gen Psychiatry. 1984;41:13–21.PubMed Weissman MM, Gershon ES, Kidd KK, Prusoff BA, Leckman JF, Dibble E, et al. Psychiatric disorders in the relatives of probands with affective disorders The Yale University, National Institute of Mental Health Collaborative Study. Arch Gen Psychiatry. 1984;41:13–21.PubMed
82.
Zurück zum Zitat Maier W, Lichtermann D, Minges J, Heun R, Hallmayer J, Benkert O. Schizoaffective disorder and affective disorders with mood-incongruent psychotic features: keep separate or combine? Evidence from a family study. Am J Psychiatry. 1992;149:1666–73.PubMed Maier W, Lichtermann D, Minges J, Heun R, Hallmayer J, Benkert O. Schizoaffective disorder and affective disorders with mood-incongruent psychotic features: keep separate or combine? Evidence from a family study. Am J Psychiatry. 1992;149:1666–73.PubMed
83.
Zurück zum Zitat Bunney WE, Davis JM. Noradrenaline in depressive reactions. A review. Arch Gen Psychiatry. 1965;13:483–94.PubMed Bunney WE, Davis JM. Noradrenaline in depressive reactions. A review. Arch Gen Psychiatry. 1965;13:483–94.PubMed
84.
Zurück zum Zitat Schildkraut JJ, Gordon EK, Durell J. Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine. J Psychiatr Res. 1965;3:213–28.PubMedCrossRef Schildkraut JJ, Gordon EK, Durell J. Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine. J Psychiatr Res. 1965;3:213–28.PubMedCrossRef
85.
86.
Zurück zum Zitat Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry. 1990;47:411–8.PubMed Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry. 1990;47:411–8.PubMed
87.
Zurück zum Zitat Miller HL, Delgado PL, Salomon RM, Berman R, Krystal JH, Heninger GR, et al. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry. 1996;53:117–28.PubMed Miller HL, Delgado PL, Salomon RM, Berman R, Krystal JH, Heninger GR, et al. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry. 1996;53:117–28.PubMed
88.
Zurück zum Zitat Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem. 1996;66:2621–4.PubMed Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem. 1996;66:2621–4.PubMed
89.
Zurück zum Zitat Heils A, Mößner R, Lesch KP. The human serotonin transporter gene polymorphism-basic research and clinical implications. J Neural Transm. 1997;104:1005–14.PubMedCrossRef Heils A, Mößner R, Lesch KP. The human serotonin transporter gene polymorphism-basic research and clinical implications. J Neural Transm. 1997;104:1005–14.PubMedCrossRef
90.
Zurück zum Zitat Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry. 1996;1:453–60.PubMed Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry. 1996;1:453–60.PubMed
91.
Zurück zum Zitat McKenzie A, Quinn J. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci USA. 1999;96:15251–5.CrossRef McKenzie A, Quinn J. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci USA. 1999;96:15251–5.CrossRef
92.
Zurück zum Zitat Abbar M, Courtet P, Amadéo S, Caer Y, Mallet J, Baldy-Moulinier MC, et al. Suicidal behaviors and the tryptophan hydroxylase gene. Arch Gen Psychiatry. 1995;52:846–9.PubMed Abbar M, Courtet P, Amadéo S, Caer Y, Mallet J, Baldy-Moulinier MC, et al. Suicidal behaviors and the tryptophan hydroxylase gene. Arch Gen Psychiatry. 1995;52:846–9.PubMed
93.
94.
Zurück zum Zitat Nielsen DA, Goldman D, Virkkunen M, Tokola R, Rawlings R, Linnoila M. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatry. 1994;51:34–8.PubMed Nielsen DA, Goldman D, Virkkunen M, Tokola R, Rawlings R, Linnoila M. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatry. 1994;51:34–8.PubMed
95.
Zurück zum Zitat Du L, Bakish D, Hrdina PD. Tryptophan hydroxylase gene 218A/C polymorphism is associated with somatic anxiety in major depressive disorder. J Affect Disord. 2001;65:37–44.PubMedCrossRef Du L, Bakish D, Hrdina PD. Tryptophan hydroxylase gene 218A/C polymorphism is associated with somatic anxiety in major depressive disorder. J Affect Disord. 2001;65:37–44.PubMedCrossRef
96.
Zurück zum Zitat Gizatullin R, Zaboli G, Jönsson EG, Asberg M, Leopardi R. The tryptophan hydroxylase (TPH) 2 gene unlike TPH-1 exhibits no association with stress-induced depression. J Affect Disord. 2008;107:175–9.PubMedCrossRef Gizatullin R, Zaboli G, Jönsson EG, Asberg M, Leopardi R. The tryptophan hydroxylase (TPH) 2 gene unlike TPH-1 exhibits no association with stress-induced depression. J Affect Disord. 2008;107:175–9.PubMedCrossRef
97.
Zurück zum Zitat Jokela M, Räikkönen K, Lehtimäki T, Rontu R, Keltikangas-Järvinen L. Tryptophan hydroxylase 1 gene (TPH1) moderates the influence of social support on depressive symptoms in adults. J Affect Disord. 2007;100:191–7.PubMedCrossRef Jokela M, Räikkönen K, Lehtimäki T, Rontu R, Keltikangas-Järvinen L. Tryptophan hydroxylase 1 gene (TPH1) moderates the influence of social support on depressive symptoms in adults. J Affect Disord. 2007;100:191–7.PubMedCrossRef
98.
Zurück zum Zitat Christenson JG, Dairman W, Udenfriend S. On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic l-amino acid decarboxylase–serotonin– dopamine–norepinephrine). Proc Natl Acad Sci USA. 1972;69:343–7.PubMedCrossRef Christenson JG, Dairman W, Udenfriend S. On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic l-amino acid decarboxylase–serotonin– dopamine–norepinephrine). Proc Natl Acad Sci USA. 1972;69:343–7.PubMedCrossRef
99.
Zurück zum Zitat Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melén K, Julkunen I, et al. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry. 1995;34:4202–10.PubMedCrossRef Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melén K, Julkunen I, et al. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry. 1995;34:4202–10.PubMedCrossRef
100.
Zurück zum Zitat Massat I, Souery D, Del-Favero J, Nothen M, Blackwood D, Muir W, et al. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol Psychiatry. 2005;10:598–605.PubMedCrossRef Massat I, Souery D, Del-Favero J, Nothen M, Blackwood D, Muir W, et al. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol Psychiatry. 2005;10:598–605.PubMedCrossRef
101.
Zurück zum Zitat Ohara K, Nagai M, Suzuki Y, Ohara K. Low activity allele of the catechol-O-methyltransferase gene and Japanese unipolar depression. Neuroreport. 1998;9:1305–8.PubMed Ohara K, Nagai M, Suzuki Y, Ohara K. Low activity allele of the catechol-O-methyltransferase gene and Japanese unipolar depression. Neuroreport. 1998;9:1305–8.PubMed
102.
Zurück zum Zitat Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav. 2002;71:533–54.PubMedCrossRef Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav. 2002;71:533–54.PubMedCrossRef
103.
Zurück zum Zitat Alex KD, Pehek EA. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther. 2007;113:296–320.PubMedCrossRef Alex KD, Pehek EA. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther. 2007;113:296–320.PubMedCrossRef
104.
Zurück zum Zitat Pucadyil TJ, Chattopadhyay A. Cholesterol modulates the antagonist-binding function of hippocampal serotonin1A receptors. Biochim Biophys Acta. 2005;1714:35–42.PubMedCrossRef Pucadyil TJ, Chattopadhyay A. Cholesterol modulates the antagonist-binding function of hippocampal serotonin1A receptors. Biochim Biophys Acta. 2005;1714:35–42.PubMedCrossRef
105.
Zurück zum Zitat Dubovsky SL, Thomas M. Serotonergic mechanisms and current and future psychiatric practice. J Clin Psychiatry. 1995;56(Suppl 2):38–48.PubMed Dubovsky SL, Thomas M. Serotonergic mechanisms and current and future psychiatric practice. J Clin Psychiatry. 1995;56(Suppl 2):38–48.PubMed
106.
Zurück zum Zitat Kapur S, Remigton G. Serotonin–Dopamine interaction and its relevance to schizophrenia. Am J Psychiatry. 1996;153:466–76.PubMed Kapur S, Remigton G. Serotonin–Dopamine interaction and its relevance to schizophrenia. Am J Psychiatry. 1996;153:466–76.PubMed
107.
Zurück zum Zitat Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, et al. Altered serotonin 1A binding in major depression: a [carbonyl-C-11] WAY100635 positron emission tomography study. Biol Psychiatry. 2006;59:106–13.PubMedCrossRef Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, et al. Altered serotonin 1A binding in major depression: a [carbonyl-C-11] WAY100635 positron emission tomography study. Biol Psychiatry. 2006;59:106–13.PubMedCrossRef
108.
Zurück zum Zitat Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci. 2003;23:8788–99.PubMed Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci. 2003;23:8788–99.PubMed
109.
Zurück zum Zitat Arias B, Catalan R, Gasto C, Gutierrez B, Fananas L. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. J Clin Psychopharmacol. 2003;23:563–7.PubMedCrossRef Arias B, Catalan R, Gasto C, Gutierrez B, Fananas L. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. J Clin Psychopharmacol. 2003;23:563–7.PubMedCrossRef
110.
Zurück zum Zitat Duman RS, Charney DS. Cell atrophy and loss in major depression. Biol Psychiatry. 1999;45:1083–4.PubMedCrossRef Duman RS, Charney DS. Cell atrophy and loss in major depression. Biol Psychiatry. 1999;45:1083–4.PubMedCrossRef
111.
Zurück zum Zitat Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron. 2002;34:13–25.PubMedCrossRef Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron. 2002;34:13–25.PubMedCrossRef
112.
Zurück zum Zitat Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF, et al. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacol. 2005;30:1353–61. Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF, et al. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacol. 2005;30:1353–61.
113.
Zurück zum Zitat Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB, et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry. 2005;58:307–14.PubMedCrossRef Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB, et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry. 2005;58:307–14.PubMedCrossRef
114.
Zurück zum Zitat Strauss J, Barr CL, George CJ, King N, Shaikh S, Devlin B, et al. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. Am J Med Genet B Neuropsychiatr Genet. 2004;131B:6–9.CrossRef Strauss J, Barr CL, George CJ, King N, Shaikh S, Devlin B, et al. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. Am J Med Genet B Neuropsychiatr Genet. 2004;131B:6–9.CrossRef
115.
Zurück zum Zitat Surtees PG, Wainwright NW, Willis-Owen SA, Sandhu MS, Luben R, Day NE, et al. No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults. J Psychiatr Res. 2007;41:404–9.PubMedCrossRef Surtees PG, Wainwright NW, Willis-Owen SA, Sandhu MS, Luben R, Day NE, et al. No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults. J Psychiatr Res. 2007;41:404–9.PubMedCrossRef
116.
Zurück zum Zitat Cohen S, Rosa A, Corsico A, Sterne A, Owen M, Korzsun A, et al. The brain derived neurotrophic factor (BDNF) Val66Met polymorphism and recurrent unipolar depression. Am J Med Genet B Neuropsychiatr Genet. 2004;130B:37–8. Cohen S, Rosa A, Corsico A, Sterne A, Owen M, Korzsun A, et al. The brain derived neurotrophic factor (BDNF) Val66Met polymorphism and recurrent unipolar depression. Am J Med Genet B Neuropsychiatr Genet. 2004;130B:37–8.
117.
Zurück zum Zitat Kim CH, Kim HS, Cubells JF, Kim KS. A previously undescribed intron and extensive 5′ upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene. J Biol Chem. 1999;274:6507–18.PubMedCrossRef Kim CH, Kim HS, Cubells JF, Kim KS. A previously undescribed intron and extensive 5′ upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene. J Biol Chem. 1999;274:6507–18.PubMedCrossRef
118.
Zurück zum Zitat Meyer J, Wiedemann P, Okladnova O, Brüss M, Staab T, Stöber G, et al. Cloning and functional characterization of the human norepinephrine transporter gene promoter. J Neural Transm. 1998;105:1341–50.PubMedCrossRef Meyer J, Wiedemann P, Okladnova O, Brüss M, Staab T, Stöber G, et al. Cloning and functional characterization of the human norepinephrine transporter gene promoter. J Neural Transm. 1998;105:1341–50.PubMedCrossRef
119.
Zurück zum Zitat Chang CC, Lu RB, Chen CL, Chu CM, Chang HA, Huang CC, et al. Lack of association between the norepinephrine transporter gene and major depression in a Han Chinese population. J Psychiatry Neurosci. 2007;32:121–8.PubMed Chang CC, Lu RB, Chen CL, Chu CM, Chang HA, Huang CC, et al. Lack of association between the norepinephrine transporter gene and major depression in a Han Chinese population. J Psychiatry Neurosci. 2007;32:121–8.PubMed
120.
Zurück zum Zitat Inoue K, Itoh K, Yoshida K, Higuchi H, Kamata M, Takahashi H, et al. No association of the G1287A polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population. Biol Pharm Bull. 2007;30:1996–8.PubMedCrossRef Inoue K, Itoh K, Yoshida K, Higuchi H, Kamata M, Takahashi H, et al. No association of the G1287A polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population. Biol Pharm Bull. 2007;30:1996–8.PubMedCrossRef
121.
Zurück zum Zitat Charney DS. Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry. 1998;59:11–4.PubMed Charney DS. Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry. 1998;59:11–4.PubMed
122.
Zurück zum Zitat Kahn RS, Davis KL. New developments in dopamine and schizophrenia. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology, the Fourth Generation of Progress. New York: Raven Press; 1995. Kahn RS, Davis KL. New developments in dopamine and schizophrenia. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology, the Fourth Generation of Progress. New York: Raven Press; 1995.
123.
Zurück zum Zitat Souery D, Lipp O, Mahieu B, Mendelbaum K, De Bruyn A, De Maertelaer V, et al. Excess of tyrosine hydroxylase restriction fragment length polymorphism homozygosity in unipolar but not bipolar patients: a preliminary report. Biol Psychiatry. 1996;40:305–8.PubMedCrossRef Souery D, Lipp O, Mahieu B, Mendelbaum K, De Bruyn A, De Maertelaer V, et al. Excess of tyrosine hydroxylase restriction fragment length polymorphism homozygosity in unipolar but not bipolar patients: a preliminary report. Biol Psychiatry. 1996;40:305–8.PubMedCrossRef
124.
Zurück zum Zitat Lim LC, Gurling H, Curtis D, Brynjolfsson J, Petursson H, Gill M. Linkage between tyrosine hydroxylase gene and affective disorder cannot be excluded in two of six pedigrees. Am J Med Genet. 1993;48:223–8.PubMedCrossRef Lim LC, Gurling H, Curtis D, Brynjolfsson J, Petursson H, Gill M. Linkage between tyrosine hydroxylase gene and affective disorder cannot be excluded in two of six pedigrees. Am J Med Genet. 1993;48:223–8.PubMedCrossRef
125.
Zurück zum Zitat Serretti A, Macciardi F, Verga M, Cusin C, Pedrini S, Smeraldi E. Tyrosine hydroxylase gene associated with depressive symptomatology in mood disorder. Am J Med Genet. 1998;81:127–30.PubMedCrossRef Serretti A, Macciardi F, Verga M, Cusin C, Pedrini S, Smeraldi E. Tyrosine hydroxylase gene associated with depressive symptomatology in mood disorder. Am J Med Genet. 1998;81:127–30.PubMedCrossRef
126.
Zurück zum Zitat Furlong RA, Rubinsztein JS, Ho L, Walsh C, Coleman TA, Muir WJ, et al. Analysis and metaanalysis of two polymorphisms within the tyrosine hydroxylase gene in bipolar and unipolar affective disorders. Am J Med Genet. 1999;88:88–94.PubMedCrossRef Furlong RA, Rubinsztein JS, Ho L, Walsh C, Coleman TA, Muir WJ, et al. Analysis and metaanalysis of two polymorphisms within the tyrosine hydroxylase gene in bipolar and unipolar affective disorders. Am J Med Genet. 1999;88:88–94.PubMedCrossRef
127.
Zurück zum Zitat Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 1990;347:146–51.PubMedCrossRef Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 1990;347:146–51.PubMedCrossRef
128.
Zurück zum Zitat Willner P, Muscat R, Phillips G. The role of dopamine in rewarded behavior: ability, insight, drive or incentive? Pol J Pharmacol Pharm. 1991;43:291–300.PubMed Willner P, Muscat R, Phillips G. The role of dopamine in rewarded behavior: ability, insight, drive or incentive? Pol J Pharmacol Pharm. 1991;43:291–300.PubMed
129.
Zurück zum Zitat Willner P, Muscat R, Papp M. An animal model of anhedonia. Clin Neuropharmacol. 1992;15:550–1. Willner P, Muscat R, Papp M. An animal model of anhedonia. Clin Neuropharmacol. 1992;15:550–1.
130.
Zurück zum Zitat Civelli O, Bunzow JR, Grandy DK. Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol. 1993;33:281–307.PubMedCrossRef Civelli O, Bunzow JR, Grandy DK. Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol. 1993;33:281–307.PubMedCrossRef
131.
Zurück zum Zitat Ross EM, Gilman AG. Biochemical properties of hormone-sensitive adenylate cyclase. Annu Rev Biochem. 1980;49:533–64.PubMedCrossRef Ross EM, Gilman AG. Biochemical properties of hormone-sensitive adenylate cyclase. Annu Rev Biochem. 1980;49:533–64.PubMedCrossRef
132.
Zurück zum Zitat Arinami T, Gao M, Hamaguchi H, Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet. 1997;6:577–82.PubMedCrossRef Arinami T, Gao M, Hamaguchi H, Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet. 1997;6:577–82.PubMedCrossRef
133.
Zurück zum Zitat Jönsson EG, Nöthen MM, Grünhage F, Farde L, Nakashima Y, Propping P, et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry. 1999;4:290–6.PubMedCrossRef Jönsson EG, Nöthen MM, Grünhage F, Farde L, Nakashima Y, Propping P, et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry. 1999;4:290–6.PubMedCrossRef
134.
Zurück zum Zitat Cravchik A, Sibley DR, Gejman PV. Functional analysis of the human D2 dopamine receptor missense variants. J Biol Chem. 1996;271:26013–7.PubMedCrossRef Cravchik A, Sibley DR, Gejman PV. Functional analysis of the human D2 dopamine receptor missense variants. J Biol Chem. 1996;271:26013–7.PubMedCrossRef
135.
Zurück zum Zitat Pohjalainen T, Rinne JO, Någren K, Lehikoinen P, Anttila K, Syvälahti EK, et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry. 1998;3:256–60.PubMedCrossRef Pohjalainen T, Rinne JO, Någren K, Lehikoinen P, Anttila K, Syvälahti EK, et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry. 1998;3:256–60.PubMedCrossRef
136.
Zurück zum Zitat Jönsson EG, Flyckt L, Burgert E, Crocq MA, Forslund K, Mattila-Evenden M, et al. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatr Genet. 2003;13:1–12.PubMedCrossRef Jönsson EG, Flyckt L, Burgert E, Crocq MA, Forslund K, Mattila-Evenden M, et al. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatr Genet. 2003;13:1–12.PubMedCrossRef
137.
Zurück zum Zitat Van Tol HH, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O, et al. Multiple dopamine D4 receptor variants in the human population. Nature. 1992;358:149–52.PubMedCrossRef Van Tol HH, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O, et al. Multiple dopamine D4 receptor variants in the human population. Nature. 1992;358:149–52.PubMedCrossRef
138.
Zurück zum Zitat Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol H. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem. 1995;65:1157–65.PubMed Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol H. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem. 1995;65:1157–65.PubMed
139.
Zurück zum Zitat Manki H, Kanba S, Muramatsu T, Higuchi S, Suzuki E, Matsushita S, et al. Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders. J Affect Disord. 1996;40:7–13.PubMedCrossRef Manki H, Kanba S, Muramatsu T, Higuchi S, Suzuki E, Matsushita S, et al. Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders. J Affect Disord. 1996;40:7–13.PubMedCrossRef
140.
Zurück zum Zitat Rees M, Norton N, Jones I, McCandless F, Scourfield J, Holmans P, et al. Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT). Mol Psychiatry. 1997;2:398–402.PubMedCrossRef Rees M, Norton N, Jones I, McCandless F, Scourfield J, Holmans P, et al. Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT). Mol Psychiatry. 1997;2:398–402.PubMedCrossRef
141.
Zurück zum Zitat Frodl T, Meisenzahl EM, Zill P, Baghai T, Rujescu D, Leinsinger G, et al. Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry. 2004;61:177–83.PubMedCrossRef Frodl T, Meisenzahl EM, Zill P, Baghai T, Rujescu D, Leinsinger G, et al. Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry. 2004;61:177–83.PubMedCrossRef
142.
Zurück zum Zitat Dannlowski U, Ohrmann P, Bauer J, Deckert J, Hohoff C, Kugel H, et al. 5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression. Neuropsychopharmacol. 2008;33:418–24.CrossRef Dannlowski U, Ohrmann P, Bauer J, Deckert J, Hohoff C, Kugel H, et al. 5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression. Neuropsychopharmacol. 2008;33:418–24.CrossRef
143.
Zurück zum Zitat Hoehe MR, Wendel B, Grunewald I, Chiaroni P, Levy N, Morris-Rosendahl D, et al. Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders. Am J Med Genet. 1998;81:1–3.PubMedCrossRef Hoehe MR, Wendel B, Grunewald I, Chiaroni P, Levy N, Morris-Rosendahl D, et al. Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders. Am J Med Genet. 1998;81:1–3.PubMedCrossRef
144.
Zurück zum Zitat Frisch A, Postilnick D, Rockah R, Michaelovsky E, Postilnick S, Birman E, et al. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Mol Psychiatry. 1999;4:389–92.PubMedCrossRef Frisch A, Postilnick D, Rockah R, Michaelovsky E, Postilnick S, Birman E, et al. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Mol Psychiatry. 1999;4:389–92.PubMedCrossRef
145.
Zurück zum Zitat Geijer T, Frisch A, Persson ML, Wasserman D, Rockah R, Michaelovsky E, et al. Search for association between suicide attempt and serotonergic polymorphisms. Psychiatr Genet. 2000;10:19–26.PubMedCrossRef Geijer T, Frisch A, Persson ML, Wasserman D, Rockah R, Michaelovsky E, et al. Search for association between suicide attempt and serotonergic polymorphisms. Psychiatr Genet. 2000;10:19–26.PubMedCrossRef
146.
Zurück zum Zitat Taylor WD, Steffens DC, Payne ME, MacFall JR, Marchuk DA, Svenson IK, et al. Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression. Arch Gen Psychiatry. 2005;62:537–44.PubMedCrossRef Taylor WD, Steffens DC, Payne ME, MacFall JR, Marchuk DA, Svenson IK, et al. Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression. Arch Gen Psychiatry. 2005;62:537–44.PubMedCrossRef
147.
Zurück zum Zitat Grünblatt E, Löffler C, Zehetmayer S, Jungwirth S, Tragl KH, Riederer P, et al. Association study of the 5-HTTLPR polymorphism and depression in 75-year-old non-demented subjects from the Vienna Transdanube Aging (VITA) study. J Clin Psychiatry. 2006;67:1373–8.PubMedCrossRef Grünblatt E, Löffler C, Zehetmayer S, Jungwirth S, Tragl KH, Riederer P, et al. Association study of the 5-HTTLPR polymorphism and depression in 75-year-old non-demented subjects from the Vienna Transdanube Aging (VITA) study. J Clin Psychiatry. 2006;67:1373–8.PubMedCrossRef
148.
Zurück zum Zitat Bellivier F, Henry C, Szöke A, Schürhoff F, Nosten-Bertrand M, Feingold J, et al. Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression. Neurosci Lett. 1998;255:143–6.PubMedCrossRef Bellivier F, Henry C, Szöke A, Schürhoff F, Nosten-Bertrand M, Feingold J, et al. Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression. Neurosci Lett. 1998;255:143–6.PubMedCrossRef
149.
Zurück zum Zitat Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES, et al. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet. 1998;81:58–63.PubMedCrossRef Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES, et al. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet. 1998;81:58–63.PubMedCrossRef
150.
Zurück zum Zitat Minov C, Baghai TC, Schüle C, Zwanzger P, Schwarz MJ, Zill P, et al. Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett. 2001;303:119–22.PubMedCrossRef Minov C, Baghai TC, Schüle C, Zwanzger P, Schwarz MJ, Zill P, et al. Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett. 2001;303:119–22.PubMedCrossRef
151.
Zurück zum Zitat Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E. Serotonin transporter gene (5-HTTLPR) and major psychoses. Mol Psychiatry. 2002;7:95–9.PubMedCrossRef Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E. Serotonin transporter gene (5-HTTLPR) and major psychoses. Mol Psychiatry. 2002;7:95–9.PubMedCrossRef
152.
Zurück zum Zitat Cervilla JA, Rivera M, Molina E, Torres-González F, Bellón JA, Moreno B, et al. The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: the PREDICT-gene study. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:912–7.PubMedCrossRef Cervilla JA, Rivera M, Molina E, Torres-González F, Bellón JA, Moreno B, et al. The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: the PREDICT-gene study. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:912–7.PubMedCrossRef
153.
Zurück zum Zitat Dorado P, Peñas-Lledó EM, González AP, Cáceres MC, Cobaleda J, Llerena A. Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 allele. Fundam Clin Pharmacol. 2007;21:451–3.PubMedCrossRef Dorado P, Peñas-Lledó EM, González AP, Cáceres MC, Cobaleda J, Llerena A. Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 allele. Fundam Clin Pharmacol. 2007;21:451–3.PubMedCrossRef
154.
Zurück zum Zitat Hickie IB, Naismith SL, Ward PB, Scott EM, Mitchell PB, Schofield PR, et al. Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression. J Affect Disord. 2007;98:137–42.PubMedCrossRef Hickie IB, Naismith SL, Ward PB, Scott EM, Mitchell PB, Schofield PR, et al. Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression. J Affect Disord. 2007;98:137–42.PubMedCrossRef
155.
Zurück zum Zitat Hauser J, Leszczyńska A, Samochowiec J, Czerski PM, Ostapowicz A, Chlopocka M, et al. Association analysis of the insertion/deletion polymorphism in serotonin transporter gene in patients with affective disorder. Eur Psychiatry. 2003;18:129–32.PubMedCrossRef Hauser J, Leszczyńska A, Samochowiec J, Czerski PM, Ostapowicz A, Chlopocka M, et al. Association analysis of the insertion/deletion polymorphism in serotonin transporter gene in patients with affective disorder. Eur Psychiatry. 2003;18:129–32.PubMedCrossRef
156.
Zurück zum Zitat Hoefgen B, Schulze TG, Ohlraun S, von Widdern O, Höfels S, Gross M, et al. The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder. Biol Psychiatry. 2005;57:247–51.PubMedCrossRef Hoefgen B, Schulze TG, Ohlraun S, von Widdern O, Höfels S, Gross M, et al. The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder. Biol Psychiatry. 2005;57:247–51.PubMedCrossRef
157.
Zurück zum Zitat Kunugi H, Hattori M, Kato T, Tatsumi M, Sakai T, Sasaki T, et al. Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder. Mol Psychiatry. 1997;2:457–62.PubMedCrossRef Kunugi H, Hattori M, Kato T, Tatsumi M, Sakai T, Sasaki T, et al. Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder. Mol Psychiatry. 1997;2:457–62.PubMedCrossRef
158.
Zurück zum Zitat Ohara K, Nagai M, Tani K, Nakamura Y, Ino A, Ohara K. Functional polymorphism of −141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia. Psychiatry Res. 1998;81:117–23.PubMedCrossRef Ohara K, Nagai M, Tani K, Nakamura Y, Ino A, Ohara K. Functional polymorphism of −141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia. Psychiatry Res. 1998;81:117–23.PubMedCrossRef
159.
Zurück zum Zitat Kim DK, Lim SW, Lee S, Sohn SE, Kim S, Hahn CG, et al. Serotonin transporter gene polymorphism and antidepressant response. Neuroreport. 2000;11:215–9.PubMed Kim DK, Lim SW, Lee S, Sohn SE, Kim S, Hahn CG, et al. Serotonin transporter gene polymorphism and antidepressant response. Neuroreport. 2000;11:215–9.PubMed
160.
Zurück zum Zitat Lotrich FE, Pollock BG. Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr Genet. 2004;14:121–9.PubMedCrossRef Lotrich FE, Pollock BG. Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr Genet. 2004;14:121–9.PubMedCrossRef
161.
Zurück zum Zitat Lasky-Su JA, Faraone SV, Glatt SJ, Tsuang MT. Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am J Med Genet Part B. 2005;133B:110–5.CrossRefPubMed Lasky-Su JA, Faraone SV, Glatt SJ, Tsuang MT. Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am J Med Genet Part B. 2005;133B:110–5.CrossRefPubMed
162.
Zurück zum Zitat DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRef DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRef
163.
Zurück zum Zitat Mendlewicz J, Massat I, Souery D, Del-Favero J, Oruc L, Nöthen MM, et al. Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study. Eur J Hum Genet. 2004;12:377–82.PubMedCrossRef Mendlewicz J, Massat I, Souery D, Del-Favero J, Oruc L, Nöthen MM, et al. Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study. Eur J Hum Genet. 2004;12:377–82.PubMedCrossRef
164.
Zurück zum Zitat Matullo G, Peluso M, Polidoro S, Guarrera S, Munnia A, Krogh V, et al. Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol Biomarkers Prev. 2003;12:674–7.PubMed Matullo G, Peluso M, Polidoro S, Guarrera S, Munnia A, Krogh V, et al. Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol Biomarkers Prev. 2003;12:674–7.PubMed
165.
Zurück zum Zitat Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1513–30.PubMed Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1513–30.PubMed
166.
Zurück zum Zitat Caporaso NE. Why have we failed to find the low penetrance genetic constituents of common cancers? Cancer Epidemiol Biomarkers Prev. 2002;11:1544–9.PubMed Caporaso NE. Why have we failed to find the low penetrance genetic constituents of common cancers? Cancer Epidemiol Biomarkers Prev. 2002;11:1544–9.PubMed
167.
Zurück zum Zitat Brennan P. Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis. 2002;23:381–7.PubMedCrossRef Brennan P. Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis. 2002;23:381–7.PubMedCrossRef
168.
Zurück zum Zitat Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM, et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depressive disorder. Lancet. 1996;347:731–3.PubMedCrossRef Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM, et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depressive disorder. Lancet. 1996;347:731–3.PubMedCrossRef
169.
Zurück zum Zitat Stöber G, Heils A, Lesch KP. Serotonin transporter gene polymorphism and affective disorder. Lancet. 1996;347:1340–1.PubMedCrossRef Stöber G, Heils A, Lesch KP. Serotonin transporter gene polymorphism and affective disorder. Lancet. 1996;347:1340–1.PubMedCrossRef
170.
Zurück zum Zitat Gutiérrez B, Pintor L, Gastó C, Rosa A, Bertranpetit J, Vieta E, et al. Variability in the serotonin transporter gene and increased risk for major depressive disorder with melancholia. Hum Genet. 1998;103:319–22.PubMedCrossRef Gutiérrez B, Pintor L, Gastó C, Rosa A, Bertranpetit J, Vieta E, et al. Variability in the serotonin transporter gene and increased risk for major depressive disorder with melancholia. Hum Genet. 1998;103:319–22.PubMedCrossRef
171.
Zurück zum Zitat Mellerup E, Bennike B, Bolwig T, Dam H, Hasholt L, Jørgensen MB, et al. Platelet serotonin transporters and the transporter gene in control subjects, unipolar patients and bipolar patients. Acta Psychiatr Scand. 2001;103:229–33.PubMedCrossRef Mellerup E, Bennike B, Bolwig T, Dam H, Hasholt L, Jørgensen MB, et al. Platelet serotonin transporters and the transporter gene in control subjects, unipolar patients and bipolar patients. Acta Psychiatr Scand. 2001;103:229–33.PubMedCrossRef
172.
Zurück zum Zitat Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P, et al. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport. 1996;7:1675–9.PubMedCrossRef Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P, et al. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport. 1996;7:1675–9.PubMedCrossRef
173.
Zurück zum Zitat Liu W, Gu N, Feng G, Li S, Bai S, Zhang J, et al. Tentative association of the serotonin transporter with schizophrenia and unipolar depression but not with bipolar disorder in Han Chinese. Pharmacogenetics. 1999;9:491–5.PubMed Liu W, Gu N, Feng G, Li S, Bai S, Zhang J, et al. Tentative association of the serotonin transporter with schizophrenia and unipolar depression but not with bipolar disorder in Han Chinese. Pharmacogenetics. 1999;9:491–5.PubMed
174.
Zurück zum Zitat Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96:434–42.PubMedCrossRef Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96:434–42.PubMedCrossRef
175.
Zurück zum Zitat Healey CS, Dunning AM, Teare MD, Chase D, Parker L, Burn J, et al. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet. 2000;26:362–4.PubMedCrossRef Healey CS, Dunning AM, Teare MD, Chase D, Parker L, Burn J, et al. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet. 2000;26:362–4.PubMedCrossRef
176.
Zurück zum Zitat Spurdle AB, Hopper JL, Chen X, Dite GS, Cui J, McCredie MR, et al. The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Cancer Epidemiol Biomarkers Prev. 2002;11:413–6.PubMed Spurdle AB, Hopper JL, Chen X, Dite GS, Cui J, McCredie MR, et al. The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Cancer Epidemiol Biomarkers Prev. 2002;11:413–6.PubMed
177.
Zurück zum Zitat d’Errico A, Taioli E, Chen X, Vineis P. Genetic metabolic polymorphisms and risk of cancer: a review of the literature. Biomerkers. 1996;1:149–73.CrossRef d’Errico A, Taioli E, Chen X, Vineis P. Genetic metabolic polymorphisms and risk of cancer: a review of the literature. Biomerkers. 1996;1:149–73.CrossRef
178.
Zurück zum Zitat Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001;10:1239–48.PubMed Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001;10:1239–48.PubMed
179.
Zurück zum Zitat Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, et al. Role of genotype in the cycle of violence in maltreated children. Science. 2002;297:851–4.PubMedCrossRef Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, et al. Role of genotype in the cycle of violence in maltreated children. Science. 2002;297:851–4.PubMedCrossRef
180.
Zurück zum Zitat Eley TC, Sugden K, Corsico A, Gregory AM, Sham P, McGuffin P, et al. Gene–environment interaction analysis or serotonin system markers with adolescent depression. Mol Psychiatry. 2004;9:908–15.PubMedCrossRef Eley TC, Sugden K, Corsico A, Gregory AM, Sham P, McGuffin P, et al. Gene–environment interaction analysis or serotonin system markers with adolescent depression. Mol Psychiatry. 2004;9:908–15.PubMedCrossRef
181.
Zurück zum Zitat Kaufman J, Yang BZ, Douglas-Palumberi H, Houshyar S, Lipschitz D, Krystal JH, et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci USA. 2004;101:17316–21.PubMedCrossRef Kaufman J, Yang BZ, Douglas-Palumberi H, Houshyar S, Lipschitz D, Krystal JH, et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci USA. 2004;101:17316–21.PubMedCrossRef
182.
Zurück zum Zitat Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry. 2005;62:529–35.PubMedCrossRef Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry. 2005;62:529–35.PubMedCrossRef
183.
Zurück zum Zitat Grabe HJ, Lange M, Wolff B, Volzke H, Lucht M, Freyberger HJ, et al. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry. 2005;10:220–4.PubMedCrossRef Grabe HJ, Lange M, Wolff B, Volzke H, Lucht M, Freyberger HJ, et al. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry. 2005;10:220–4.PubMedCrossRef
184.
Zurück zum Zitat Zalsman G, Huang YY, Oquendo MA, Burke AK, Hu XZ, Brent DA, et al. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry. 2006;163:1588–93.PubMedCrossRef Zalsman G, Huang YY, Oquendo MA, Burke AK, Hu XZ, Brent DA, et al. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry. 2006;163:1588–93.PubMedCrossRef
185.
Zurück zum Zitat Sjöberg RL, Nilsson KW, Nordquist N, Ohrvik J, Leppert J, Lindström L, et al. Development of depression: sex and the interaction between environment and a promoter polymorphism of the serotonin transporter gene. Int J Neuropsychopharmacol. 2006;9:443–9.PubMedCrossRef Sjöberg RL, Nilsson KW, Nordquist N, Ohrvik J, Leppert J, Lindström L, et al. Development of depression: sex and the interaction between environment and a promoter polymorphism of the serotonin transporter gene. Int J Neuropsychopharmacol. 2006;9:443–9.PubMedCrossRef
186.
Zurück zum Zitat Wilhelm K, Mitchell PB, Niven H, Finch A, Wedgwood L, Scimone A, et al. Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry. 2006;188:210–5.PubMedCrossRef Wilhelm K, Mitchell PB, Niven H, Finch A, Wedgwood L, Scimone A, et al. Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry. 2006;188:210–5.PubMedCrossRef
187.
Zurück zum Zitat Gillespie NA, Whitfield JB, Williams B, Heath AC, Martin NG. The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression. Psychol Med. 2005;35:101–11.PubMedCrossRef Gillespie NA, Whitfield JB, Williams B, Heath AC, Martin NG. The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression. Psychol Med. 2005;35:101–11.PubMedCrossRef
188.
Zurück zum Zitat Surtees PG, Wainwright NW, Willis-Owen SA, Luben R, Day NE, Flint J. Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder. Biol Psychiatry. 2006;59:224–9.PubMedCrossRef Surtees PG, Wainwright NW, Willis-Owen SA, Luben R, Day NE, Flint J. Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder. Biol Psychiatry. 2006;59:224–9.PubMedCrossRef
189.
Zurück zum Zitat Brown GW, Harris TO. Depression and the serotonin transporter 5-HTTLPR polymorphism: a review and a hypothesis concerning gene–environment interaction. J Affect Disord. 2008;111:1–12.PubMedCrossRef Brown GW, Harris TO. Depression and the serotonin transporter 5-HTTLPR polymorphism: a review and a hypothesis concerning gene–environment interaction. J Affect Disord. 2008;111:1–12.PubMedCrossRef
190.
Zurück zum Zitat Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE, et al. Haplotype variation and linkage disequilibrium in 313 human genes. Science. 2001;293:489–93.PubMedCrossRef Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE, et al. Haplotype variation and linkage disequilibrium in 313 human genes. Science. 2001;293:489–93.PubMedCrossRef
191.
Zurück zum Zitat Judson R, Stephens JC, Windemuth A. The predictive power of haplotypes in clinical response. Pharmacogenomics. 2000;1:15–26.PubMedCrossRef Judson R, Stephens JC, Windemuth A. The predictive power of haplotypes in clinical response. Pharmacogenomics. 2000;1:15–26.PubMedCrossRef
192.
Zurück zum Zitat Fallin D, Cohen A, Essioux L, Chumakov I, Blumenfeld M, Cohen D, et al. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer’s disease. Genome Res. 2001;11:143–51.PubMedCrossRef Fallin D, Cohen A, Essioux L, Chumakov I, Blumenfeld M, Cohen D, et al. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer’s disease. Genome Res. 2001;11:143–51.PubMedCrossRef
193.
Zurück zum Zitat Khoury M, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. Monographs in epidemiology and biostatistics. New York: NY Oxford University Press; 1993. p. 144–5. Khoury M, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. Monographs in epidemiology and biostatistics. New York: NY Oxford University Press; 1993. p. 144–5.
194.
Zurück zum Zitat Hoh J, Wille A, Ott J. Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res. 2001;11:2115–9.PubMedCrossRef Hoh J, Wille A, Ott J. Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res. 2001;11:2115–9.PubMedCrossRef
Metadaten
Titel
Molecular epidemiology of major depressive disorder
verfasst von
Chikako Kiyohara
Kouichi Yoshimasu
Publikationsdatum
01.03.2009
Verlag
Springer Japan
Erschienen in
Environmental Health and Preventive Medicine / Ausgabe 2/2009
Print ISSN: 1342-078X
Elektronische ISSN: 1347-4715
DOI
https://doi.org/10.1007/s12199-008-0073-6

Weitere Artikel der Ausgabe 2/2009

Environmental Health and Preventive Medicine 2/2009 Zur Ausgabe